Immunoluminescent detection of intercellular adhesion molecule-1 and aminopeptidase N on human melanoma cells

Anticancer Research

Volumn 27, Issue 4 A, 2007, Pages 2047-2052

  Laube, Friedemann ^a  

^a MARTIN LUTHER UNIVERSITY HALLE WITTENBERG   (Germany)

Author keywords

Activity inhibition assay for APN; Aminopeptidase N (APN CD13); Immunoluminescence; Intercellular adhesion molecule 1 (ICAM 1 CD54); Melanoma cells

Indexed keywords

ALANINE 4 NITROANILIDE; ANILIDE; HORSERADISH PEROXIDASE; INTERCELLULAR ADHESION MOLECULE 1; MICROSOMAL AMINOPEPTIDASE; UNCLASSIFIED DRUG;

CELL SURFACE; CELL VIABILITY; CONFERENCE PAPER; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME ANALYSIS; HUMAN; HUMAN CELL; LUMINESCENCE; MELANOMA; PRIORITY JOURNAL;

ANTIGENS, CD13; CELL LINE, TUMOR; HUMANS; IMMUNOHISTOCHEMISTRY; INTERCELLULAR ADHESION MOLECULE-1; LUMINESCENT MEASUREMENTS; MELANOMA; NEOPLASM INVASIVENESS;

EID: 34250789602     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (45)

1. Reuning U, Magdolen V, Wilhelm O, Fischer K, Lutz V, Graeff H and Schmitt M: Multifunctional potential of the plasminogen activation system in tumor invasion and metastasis. Int J Oncol 13: 893-906, 1998.
2. Aozuka Y, Koizumi K, Saitoh Y, Ueda Y, Sakurai H and Saiki I: Anti-tumor angiogenesis effect of aminopeptidase inhibitor bestatin against B16-BL6 melanoma cells orthotopically implanted into syngeneic mice. Cancer Lett 216: 35-42, 2004.
3. Bauvois B: Transmembrane proteases in cell growth and invasion: new contributors to angiogenesis? Oncogene 23: 317-329, 2004.
4. Laube F: Co-localization of CD44 and urokinase-type plasminogen activator on the surface of human melanoma cells. Anticancer Res 20: 5045-5048, 2000.
5. Laube F, Göhring B, Sann H and Willhardt I: Cell surface antigens in renal tumor cells: detection by immunoluminescence and enzymatic analysis. Br J Cancer 85: 924-929, 2001.
6. Laube F: Cell surface expression of CD44: detection on tumor cells by immunoluminescence compared to fluorescence analysis. In: Bioluminescence and Chemiluminescence - Perspectives for the 21st Century. Roda A, Pazzagli M, Kricka LJ and Stanley PE (eds.). Chichester, J. Wiley and Sons, pp. 126-129, 1999.
7. Lasch J, Moschner S and Koelsch R: Aminopeptidase P - a cell-surface antigen of endothelial and lymphoid cells. Adv Exp Med Biol 421: 17-23, 1997.
8. Lasch J, Moschner S, Sann H, Zellmer S and Koelsch R: Aminopeptidase P - a cell-surface antigen of endothelial and lymphoid cells: catalytic and immuno-histotopical evidence. Biol Chem 379: 705-709, 1998.
9. Van de Stolpe A and Van der Saag PT: Intercellular adhesion molecule-1. J Mol Med 74: 13-33, 1996.
10. Hayflick JS, Kilgannon P and Gallatin WM: The intercellular adhesion molecule (ICAM) family of proteins - new members and novel functions. Immunol Res 17: 313-327, 1998.
11. Neeson PJ, Thurlow PJ, Jamieson GP and Bradley C: Lymphocyte-facilitated tumour cell adhesion to endothelial cells: the role of high affinity leucocyte integrins. Pathology 35: 50-55, 2003.
12. Johnson JP: Cell adhesion molecules of the immunoglobulin supergene family and their role in malignant transformation and progression to metastatic disease. Cancer Metast Rev 10: 11-22, 1991.
13. Becker JC and Bröcker EB: Lymphocyte - melanoma interaction: role of surface molecules. Recent Results Cancer Res 139: 205-214, 1995.
14. Edward M and MacKie RM: Cell-cell and cell-extracellular matrix interaction during melanoma cell invasion and metastasis. Melanoma Res 3: 227-234, 1993.
15. Rice GE and Bevilacqua MP: An inducible endothelial cell surface glycoprotein mediates melanoma adhesion. Science 246: 1303-1306, 1989.
16. Nanus DM, Papandreou CN and Albino AP: Expression of cell-surface peptidases in neoplastic cells. In: Cell-surface Peptidases in Health and Disease. Kenny AJ and Boustead CM (eds.). Oxford, BIOS Scientific Publishers, pp. 353-369, 1997.
17. Noren O, Sjöström H and Olsen J: Aminopeptidase N. In: Cell-surface Peptidases in Health and Disease. Kenny AJ and Boustead CM (eds.). Oxford, BIOS Scientific Publishers, pp. 175-191, 1997.
18. Lendeckel U, Arndt M, Firla B, Wolke C, Wex T and Ansorge S: CD13/APN in hematopoetic cells - expression, function, regulation, and clinical aspects. In: Ectopeptidases. Langner J and Ansorge S (eds.). New York, Kluwer Academic/Plenum Publishers, pp. 25-49, 2002.
19. Tsushima H and Hopsu-Havu VK: A chloride activated alanine aminopeptidase from a melanoma cell line. Neoplasma 37: 415-425, 1990.
20. Saiki I, Fujii H, Yoneda J, Abe F, Nakajima M, Tsuruo T and Azuma I: Role of aminopeptidase N (CD13) in tumor-cell invasion and extracellular matrix degradation. Int J Cancer 54: 137-143, 1993.
21. Menrad A, Speicher D, Wacker J and Herlyn M: Biochemical and functional characterization of aminopeptidase N expressed by human melanoma cells. Cancer Res 53: 1450-1455, 1993.
22. Fujii H, Nakajima M, Saiki I, Yoneda J, Azuma I and Tsuruo T: Human melanoma invasion and metastasis enhancement by high expression of aminopeptidase N/CD13. Clin Exp Metastasis 13: 337-344, 1995.
23. Aubert C, Rouge F and Galindo JR: Tumorigenicity of human malignant melanocytes in nude mice in relation to their differentiation in vitro. J Nat Cancer Inst 64: 1029-1040, 1980.
24. Kricka LJ and Thorpe GHG: Bioluminescent and chemiluminescent detection of horseradish peroxidase labels in ligand binder assays. In: Luminescence Immunoassay and Molecular Applications. Van Dyke K and Van Dyke R (eds.). Boca Raton, CRC Press, pp. 77-98, 1990.
25. Riemann D, Blosz T, Wulfänger J, Langner J and Navarrete Santos A: Signal transduction via membrane peptidases. In: Ectopeptidases. Langner J and Ansorge S (eds.). New York, Kluwer Academic/Plenum Publishers, pp. 141-170, 2002.
26. Riemann D, Kehlen A and Langner J: Stimulation of the expression and the enzyme activity of aminopeptidase N/CD13 and dipeptidylpeptidase IV/CD26 on human renal cell carcinoma cells and renal tubular epithelial cells by T cell-derived cytokines, such as IL-4 and IL-13. Clin Exp Immunol 100: 277-283, 1995.
27. Mrestani-Klaus C, Lorey S, Faust J, Bühling F and Neubert K: Detection of the activity of the ectopeptidases DP IV and APN using sensitive fluorogenic substrates. In: Ectopeptidases. Langner J and Ansorge S (eds). New York, Kluwer Academic/Plenum Publishers, pp. 1-24, 2002.
28. Griffioen AW, Damen CA, Martinotti S, Blijham GH and Groenewegen G: Endothelial intercellular adhesion molecule-1 expression is suppressed in human malignancies: the role of angiogenic factors. Cancer Res 56: 1111-1117, 1996.
29. Fujisaki T, Tanaka Y, Fujii K, Mine S, Saito K, Yamada S, Yamashita U, Irimura T and Eto S: CD44 stimulation induces integrin-mediated adhesion of colon cancer cell lines to endothelial cells by up-regulation of integrins and c-Met and activation of integrins. Cancer Res 59: 4427-4434, 1999.
30. Altomonte M, Colizzi F, Esposito G and Maio M: Circulating intercellular adhesion molecule 1 as a marker of disease progression in cutaneous melanoma. N Engl J Med 327: 959, 1992.
31. Harning R, Mainolfi E, Bystryn JC, Henn M, Merluzzi VJ and Rothlein R: Serum levels of circulating intercellular adhesion molecule 1 in human malignant melanoma. Cancer Res 51: 5003-5005, 1991.
32. Yasasever V, Tas F, Duranyildiz D, Camlica H, Kurul S and Dalay N: Serum levels of the soluble adhesion molecules in patients with malignant melanoma. Pathol Oncol Res 6: 42-45, 2000.
33. Pasqualini R, Koivunen E, Kain R, Lahdenranta J, Sakamoto M, Stryhn A, Ashmun RA, Shapiro LH, Arap W and Ruoslahti E: Aminopeptidase N is a receptor for tumor-homing peptides and a target for inhibiting angiogenesis. Cancer Res 60: 722-727, 2000.
34. Xu Y, Lai LT, Gabrilove JL and Scheinberg DA: Antitumor activity of actinonin in vitro and in vivo. Clin Cancer Res 4: 171-176, 1998.
35. Grujic M and Renko M: Aminopeptidase inhibitors bestatin and actinonin inhibit cell proliferation of myeloma cells predominantly by intracellular interactions. Cancer Lett 182: 113-119, 2002.
36. Lee MD, She Y, Soskis MJ, Borella CP, Gardner JR, Hayes PA, Dy BM, Heaney ML, Philips MR, Bornmann WG, Sirotnak FM and Scheinberg DA: Human mitochondrial peptide deformylase, a new anticancer target of actinonin-based antibiotics. J Clin Invest 114: 1107-1116, 2004.
37. Shim JS, Kim JH, Cho HY, Yum YN, Kim SH, Park HJ, Shim BS, Choi SH and Kwon HJ: Irreversible inhibition of CD13/aminopeptidase N by the antiangiogenic agent curcumin. Chem Biol 10: 695-704, 2003.
38. Sharma RA, Gescher AJ and Steward WP: Curcumin: the story so far. Eur J Cancer 41: 1955-1968, 2005.
39. Yokoyama Y and Ramakrishnan S: Addition of an aminopeptidase N-binding sequence to human endostatin improves inhibition of ovarian carcinoma growth. Cancer 104: 321-331, 2005.
40. Yokoyama Y and Ramakrishnan S: Addition of integrin binding sequence to a mutant human endostatin improves inhibition of tumor growth. Int J Cancer 111: 839-848, 2004.
41. O'Reilly MS, Boehm T, Shing Y, Fukai N, Vasios G, Lane WS, Flynn E, Birkhead JR, Olsen BR and Folkman J: Endostatin: an endogenous inhibitor of angiogenesis and tumor growth. Cell 88: 277-285, 1997.
42. Clamp AR and Jayson GC: The clinical potential of antiangiogenic fragments of extracellular matrix proteins. Br J Cancer 93: 967-972, 2005.
43. Hansma AHG, Broxterman HJ, van der Horst I, Yuana Y, Boven E, Giaccone G, Pinedo HM and Hoekman K: Recombinant human endostatin administered as a 28-day continuous intravenous infusion, followed by daily subcutaneous injections: a phase I and pharmacokinetic study in patients with advanced cancer. Annals Oncol 16: 1695-1701, 2005.
44. Oehler MK and Bicknell R: The promise of anti-angiogenic cancer therapy. Br J Cancer 82: 749-752, 2000.
45. Pasco S, Ramont L, Maquart FX and Monboisse JC: Control of melanoma progression by various matrikines from basement membrane macromolecules. Critic Rev Oncol Hematol 49: 221-233, 2004.